TransCode Therapeutics In...
(RNAZ)
undefined
undefined%
At close: undefined
3.45
-1.14%
Pre-market Jan 07, 2025, 06:18 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -2.1 | -8.09 | -101.79 | -406.93 | -1.17K | -1.97K |
| PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 23.72 | 87.72 | 34.61 | -326.95 | -806.26 | -1.78K |
| P/FCF Ratio | -2.15 | -17.92 | -127.9 | -2.26K | -1.76K | -2.99K |
| P/OCF Ratio | -2.15 | -18.03 | -134.09 | -2.26K | -1.76K | -2.99K |
| OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | n/a | n/a | n/a | -0.61 | -0.84 | -0.94 |
| Quick Ratio | 1.28 | 1.57 | 8.97 | 2.05 | 3.25 | 1.82 |
| Current Ratio | 1.28 | 1.70 | 8.97 | 2.05 | 3.25 | 1.82 |
| Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -383.66 | -1.06 | -64.7 | -1.84 | -2.91 | n/a |
| Return on Equity (ROE) | -11.3 | -10.84 | -0.34 | 0.80 | 0.69 | 0.90 |
| Return on Assets (ROA) | -3.59 | -4.63 | -0.3 | -2.59 | -3.74 | -2.11 |
| Return on Capital (ROIC) | -11.56 | -5.76 | -0.3 | -1.12 | -3.23 | -3.96 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |